Polymerase Acidic Endonuclease Inhibitor [EPC] - N0000193852

Pharmacologic Class Information

Pharmacologic Code N0000193852
Pharmacologic Name Polymerase Acidic Endonuclease Inhibitor
Pharmacologic Uses
  • polymerase acidic (PA) endonuclease inhibitor
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Polymerase Acidic Endonuclease Inhibitor

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Polymerase Acidic Endonuclease Inhibitor [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
50242-583Xofluza Non-Proprietary Name: Baloxavir MarboxilGranule, For SolutionOralGenentech, Inc.ACTIVE
50242-860Xofluza Non-Proprietary Name: Baloxavir MarboxilTablet, Film CoatedOralGenentech, Inc.ACTIVE
50242-877Xofluza Non-Proprietary Name: Baloxavir MarboxilTablet, Film CoatedOralGenentech, Inc.ACTIVE